Blood test could sharpen lung cancer screening, study says

NCT ID NCT03774758

First seen Jun 12, 2026 · Last updated Jun 16, 2026 · Updated 2 times

Summary

This study is testing a blood test that looks for tumor DNA to see if it can more accurately tell whether a lung nodule found on a CT scan is cancer. About 590 people getting lung cancer screening will give blood samples and be followed for 3 years. The goal is to improve how we decide which nodules need further testing, reducing unnecessary procedures.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NODULE SOLITARY PULMONARY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • San Francisco VA Medical Center

    RECRUITING

    San Francisco, California, 94121, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94122, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Zuckerberg San Francisco General Hospital and Trauma Center

    RECRUITING

    San Francisco, California, 94110, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.